This site uses cookies to enhance your experience. By continuing to browse you accept our Cookie Policy.
Illustration showing mRNA strand linking Covid vaccines to cancer therapies

MARKET TRENDS

24 Oct 2025

From Covid to Cancer, Europe’s mRNA Strategy Takes Shape

Targeted funding and new facilities show a steady push to extend mRNA science beyond Covid-era vaccines

Moderna sign at UK mRNA research and manufacturing hub in Oxfordshire

INSIGHTS

25 Sep 2025

UK mRNA Hub Signals a New Chapter for Biotech Growth

New Oxfordshire facility strengthens vaccine production and positions UK as key player in mRNA therapeutics

AI-inspired illustration showing mRNA strands and digital data processing

INNOVATION

31 Aug 2025

A Faster Future for mRNA, Powered by AI

GEMORNA advances mRNA design with AI and shows strong gains in early research

Antibody-guided lipid nanoparticle model for targeted mRNA delivery

INNOVATION

9 Aug 2025

How Smarter Delivery Could Redefine mRNA Therapies

Preclinical antibody-guided delivery suggests mRNA could move beyond vaccines toward more precise cancer and immune therapies

Scientific illustration of lipid nanoparticles central to mRNA delivery systems

TECHNOLOGY

2 Aug 2025

How Lipid Engineering Is Becoming mRNA’s Critical Advantage

Peer-reviewed research shows redesigned lipid nanoparticles can reduce toxicity without sacrificing delivery, fueling growing expert inter...

BioNTech headquarters following announcement of CureVac acquisition deal

INVESTMENT

18 Jun 2025

Why BioNTech’s CureVac Move Matters Far Beyond Vaccines

BioNTech’s all-share purchase of CureVac sharpens Europe’s focus on mRNA therapies beyond Covid-19

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.